Tandem Diabetes Care (TNDM) Assets Average (2014 - 2026)

Tandem Diabetes Care's Assets Average history runs 13 years deep, the most recent figure standing at $1.0 billion for Q1 2026.

• Quarterly Assets Average rose 7.66% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 billion (up 7.66% YoY) and the FY2025 annual result came in at $924.4 million, down 3.73% from the prior year.
• Assets Average was $1.0 billion for Q1 2026 at Tandem Diabetes Care, up from $877.9 million in the prior quarter.
• Across five years, Assets Average topped out at $1.1 billion in Q4 2022 and bottomed at $875.2 million in Q3 2025.
• A 5-year average of $960.7 million and a median of $947.6 million in 2024 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average jumped 32.42% — and 2023, when it declined 9.89%.
• Tandem Diabetes Care's Assets Average stood at $1.1 billion in 2022, then fell by 9.89% to $946.3 million in 2023, then increased by 1.73% to $962.7 million in 2024, then decreased by 8.81% to $877.9 million in 2025, then grew by 15.88% to $1.0 billion in 2026.
• Business Quant data shows TNDM's Assets Average at $1.0 billion in Q1 2026, $877.9 million in Q4 2025, and $875.2 million in Q3 2025.